StreetAlpha.app
Home › Stocks › SHC

Sotera Health Co (SHC)

Healthcare
$16.05
▼ −1.23%
LAST CLOSE · NOV 17

Sotera Health provides outsourced sterilization services and Co-60 radiation sources for medical device, drug and food companies. It last closed at $16.05 on Nov 17, down 1.23% on the day. The average 12-month price target from 2 analysts is $17.50 (+9.0% from the last close), with a high of $20.00 and a low of $15.00. In the past 30 days there were 2 dark pool prints totaling $1.4M, the largest $866K.

AI Auto Pilots
Is SHC in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$1.2B
+6.9% vs a year ago
Net income
$173.5M
+213.0% vs a year ago
EPS (diluted)
$0.60
+200.0% vs a year ago
Free cash flow
$135.4M
11.0% margin
Valuation
Market cap
$4.6B
285.6M shares
P/E
26.8
Price over 12 month EPS
Price to sales
3.7
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$412.4M
At Sep 30
Debt
$2.1B
At Sep 30
Shareholder equity
$733.2M
Shares outstanding
285.6M
At Oct 27
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $931.5M$931.5MFY2021FY2022: $1.0B$1.0BFY2022FY2023: $1.0B$1.0BFY2023FY2024: $1.1B$1.1BFY2024FY2025: $1.2B$1.2BFY2025

From SHC's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 3). Last 12 months adds up the four latest quarters.

Next report
—
No date on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
1 Buy · 1 Sell
2 firms · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy · 1 Sell
2firms
1 Buy0 Hold1 Sell
Only 2 firms rated SHC in the past 90 days, not enough for a consensus
Average 12-month target
$17.50
▲ 9.0% upside

Based on 2 analysts who set a price target on SHC in the past 90 days. The average target is $17.50, with a high of $20.00 and a low of $15.00, compared with the last close of $16.05.

Low $15.00Avg $17.50High $20.00
Blue marker: last close $16.05
Highest target$20.00
Average target$17.50
Lowest target$15.00
Latest rating changes
JP MorganTarget lowered
Nov 4Sell$17 → $15
BarclaysTarget lowered
Nov 4Buy$22 → $20
JP MorganDowngrade
Oct 14Sell$18 → $17
CitigroupMaintained
Aug 7Buy$25
BarclaysTarget raised
Aug 7Buy$19 → $22
DateFirmActionRatingPrice target
Nov 4JP MorganTarget loweredSell$17 → $15
Nov 4BarclaysTarget loweredBuy$22 → $20
Oct 14JP MorganDowngradeSell$18 → $17
Aug 7CitigroupMaintainedBuy$25
Aug 7BarclaysTarget raisedBuy$19 → $22
Loading…

Technical Analysis

SHC · as of the Nov 17 close · updated after every close
Turning down, nearing oversold

The stock is 7% below its 20 day and 11% below its 50 day average. It is 5% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 36), near oversold. The nearest support is the Pivot S1 at $15.88, and the nearest resistance the swing high (May 27) at $16.10.

Short trendBearish
Long trendNeutral
MomentumWeak
StretchNear oversold
VolatilityHigh, 3.5%/day
Key levels
$19.8552 week high+23.7%
$18.11100 day average+12.8%
$17.8650 day average+11.3%
$17.1420 day average+6.8%
$16.87200 day average+5.1%
$16.29Pivot R1+1.5%
$16.12Pivot+0.4%
$16.10Swing high (May 27)+0.3%
$16.05Last close
$15.88Pivot S1−1.1%
$15.64Swing low (Nov 6)−2.6%
$13.0952 week low−18.4%
Indicators
RSI (14)36.41Weak, oversold below 30Neutral
MACD-0.53Below its signal lineBearish
Stochastic19.9Near the bottom of its rangeOversold
ADX (14)23.2Weak trend
Williams %R-87.8Oversold below −80, overbought above −20Oversold
CCI (20)-71.8Oversold below −100, overbought above 100Neutral
Rate of change+0.1%Change over 10 sessionsBullish
ATR (14)$0.56Typical daily range, 3.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for SHC

What happened before

See how SHC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow SHC usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How SHC has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in SHC in the last 90 days.

Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
2
Notional
$1.4M
Largest print
$866K
Loading…

SHC Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲226 buying vs 105 selling
  • ▼Held by funds -4.5 pts
  • ▲Funds holding +28
  • ▼Superinvestors: 1 added, 4 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding348320+8.8%
In funds' top 101415−6.7%
Held by funds98.9%103.5%−4.5 pts
New / increased68 / 15854 / 164+3.7%
Reduced / sold out72 / 3367 / 35+2.9%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See SHC institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SHC is in one of them and how their past SHC trades turned out.

SHC in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered SHC in an article yet. Here's the latest on the wider market.

About Sotera Health

Sotera Health provides outsourced sterilization services that help ensure medical devices, pharmaceuticals, and food products are safe for use. Its Sterigenics business sterilizes products in their final packaging using gamma, ethylene oxide, and electron beam methods, and also offers microbial reduction for food and irradiation services for industrial materials. Its Nordion business supplies Co-60, a radioactive isotope used in gamma sterilization and cancer treatment, along with gamma irradiation systems. Customers include medical device makers, drug companies, food producers, and other manufacturers, and the company is based in Broadview Heights, Ohio.

Headquarters
Broadview Heights, OH